|
CHEMBL253
|
P34972
|
Cannabinoid CB2 receptor |
99.59%
|
97.25%
|
|
CHEMBL3837
|
P07711
|
Cathepsin L |
99.59%
|
96.61%
|
|
CHEMBL2581
|
P07339
|
Cathepsin D |
99.52%
|
98.95%
|
|
CHEMBL220
|
P22303
|
Acetylcholinesterase |
99.07%
|
94.45%
|
|
CHEMBL4018
|
P49146
|
Neuropeptide Y receptor type 2 |
98.91%
|
98.94%
|
|
CHEMBL1795139
|
Q8IU80
|
Transmembrane protease serine 6 |
98.83%
|
98.33%
|
|
CHEMBL3251
|
P19838
|
Nuclear factor NF-kappa-B p105 subunit |
98.42%
|
96.09%
|
|
CHEMBL2730
|
P21980
|
Protein-glutamine gamma-glutamyltransferase |
98.11%
|
92.38%
|
|
CHEMBL3359
|
P21462
|
Formyl peptide receptor 1 |
98.06%
|
93.56%
|
|
CHEMBL3024
|
P53350
|
Serine/threonine-protein kinase PLK1 |
97.86%
|
97.43%
|
|
CHEMBL4123
|
P30989
|
Neurotensin receptor 1 |
97.24%
|
96.67%
|
|
CHEMBL259
|
P32245
|
Melanocortin receptor 4 |
96.34%
|
95.38%
|
|
CHEMBL237
|
P41145
|
Kappa opioid receptor |
96.10%
|
98.10%
|
|
CHEMBL4625
|
Q07817
|
Apoptosis regulator Bcl-X |
95.81%
|
99.77%
|
|
CHEMBL2514
|
O95665
|
Neurotensin receptor 2 |
94.95%
|
100.00%
|
|
CHEMBL4227
|
P25090
|
Lipoxin A4 receptor |
94.80%
|
100.00%
|
|
CHEMBL4801
|
P29466
|
Caspase-1 |
94.79%
|
96.85%
|
|
CHEMBL3468
|
P55210
|
Caspase-7 |
94.19%
|
95.68%
|
|
CHEMBL4478
|
Q00975
|
Voltage-gated N-type calcium channel alpha-1B subunit |
94.15%
|
97.14%
|
|
CHEMBL3130
|
O00329
|
PI3-kinase p110-delta subunit |
94.11%
|
96.47%
|
|
CHEMBL3437
|
Q16853
|
Amine oxidase, copper containing |
94.07%
|
94.00%
|
|
CHEMBL340
|
P08684
|
Cytochrome P450 3A4 |
93.99%
|
91.19%
|
|
CHEMBL4394
|
Q9NYA1
|
Sphingosine kinase 1 |
93.87%
|
96.03%
|
|
CHEMBL1944495
|
P28065
|
Proteasome subunit beta type-9 |
93.58%
|
97.50%
|
|
CHEMBL333
|
P08253
|
Matrix metalloproteinase-2 |
93.45%
|
96.31%
|
|
CHEMBL1907591
|
P30926
|
Neuronal acetylcholine receptor; alpha4/beta4 |
93.37%
|
100.00%
|
|
CHEMBL2693
|
Q9UIQ6
|
Cystinyl aminopeptidase |
93.28%
|
97.64%
|
|
CHEMBL3137262
|
O60341
|
LSD1/CoREST complex |
93.25%
|
97.09%
|
|
CHEMBL4777
|
P25929
|
Neuropeptide Y receptor type 1 |
92.88%
|
96.67%
|
|
CHEMBL4588
|
P22894
|
Matrix metalloproteinase 8 |
92.46%
|
94.66%
|
|
CHEMBL3176
|
O43603
|
Galanin receptor 2 |
92.35%
|
98.89%
|
|
CHEMBL4979
|
P13866
|
Sodium/glucose cotransporter 1 |
91.78%
|
98.24%
|
|
CHEMBL206
|
P03372
|
Estrogen receptor alpha |
91.68%
|
97.64%
|
|
CHEMBL2073
|
P07947
|
Tyrosine-protein kinase YES |
91.58%
|
83.14%
|
|
CHEMBL2094135
|
Q96BI3
|
Gamma-secretase |
91.39%
|
98.05%
|
|
CHEMBL3880
|
P07900
|
Heat shock protein HSP 90-alpha |
91.07%
|
96.21%
|
|
CHEMBL321
|
P14780
|
Matrix metalloproteinase 9 |
89.92%
|
92.12%
|
|
CHEMBL5103
|
Q969S8
|
Histone deacetylase 10 |
89.39%
|
90.08%
|
|
CHEMBL3807
|
P17706
|
T-cell protein-tyrosine phosphatase |
88.76%
|
93.00%
|
|
CHEMBL2111367
|
P27986
|
PI3-kinase p110-alpha/p85-alpha |
88.40%
|
94.33%
|
|
CHEMBL274
|
P51681
|
C-C chemokine receptor type 5 |
87.88%
|
98.77%
|
|
CHEMBL3267
|
P48736
|
PI3-kinase p110-gamma subunit |
87.56%
|
95.71%
|
|
CHEMBL5163
|
Q9NY46
|
Sodium channel protein type III alpha subunit |
87.27%
|
96.90%
|
|
CHEMBL5845
|
P23415
|
Glycine receptor subunit alpha-1 |
87.24%
|
90.71%
|
|
CHEMBL5608
|
Q16288
|
NT-3 growth factor receptor |
86.97%
|
95.89%
|
|
CHEMBL4026
|
P40763
|
Signal transducer and activator of transcription 3 |
86.68%
|
82.69%
|
|
CHEMBL255
|
P29275
|
Adenosine A2b receptor |
86.67%
|
98.59%
|
|
CHEMBL2274
|
Q9H228
|
Sphingosine 1-phosphate receptor Edg-8 |
86.38%
|
100.00%
|
|
CHEMBL3691
|
Q13822
|
Autotaxin |
86.28%
|
96.39%
|
|
CHEMBL5043
|
Q6P179
|
Endoplasmic reticulum aminopeptidase 2 |
86.24%
|
91.81%
|
|
CHEMBL3430907
|
Q96GD4
|
Aurora kinase B/Inner centromere protein |
86.05%
|
97.50%
|
|
CHEMBL3060
|
Q9Y345
|
Glycine transporter 2 |
86.03%
|
99.17%
|
|
CHEMBL2107
|
P61073
|
C-X-C chemokine receptor type 4 |
85.86%
|
93.10%
|
|
CHEMBL2815
|
P04629
|
Nerve growth factor receptor Trk-A |
85.85%
|
87.16%
|
|
CHEMBL236
|
P41143
|
Delta opioid receptor |
85.78%
|
99.35%
|
|
CHEMBL4187
|
Q99250
|
Sodium channel protein type II alpha subunit |
85.71%
|
95.50%
|
|
CHEMBL2413
|
P32246
|
C-C chemokine receptor type 1 |
85.65%
|
89.50%
|
|
CHEMBL4816
|
Q9Y243
|
Serine/threonine-protein kinase AKT3 |
85.59%
|
96.28%
|
|
CHEMBL4005
|
P42336
|
PI3-kinase p110-alpha subunit |
85.42%
|
97.47%
|
|
CHEMBL3392948
|
Q9NP59
|
Solute carrier family 40 member 1 |
85.24%
|
95.00%
|
|
CHEMBL1907594
|
P30926
|
Neuronal acetylcholine receptor; alpha3/beta4 |
84.23%
|
97.23%
|
|
CHEMBL3018
|
Q9Y5Y6
|
Matriptase |
83.92%
|
98.33%
|
|
CHEMBL2095194
|
P08709
|
Coagulation factor VII/tissue factor |
83.85%
|
99.17%
|
|
CHEMBL2095164
|
P49354
|
Geranylgeranyl transferase type I |
83.82%
|
92.80%
|
|
CHEMBL3830
|
Q2M2I8
|
Adaptor-associated kinase |
83.78%
|
83.10%
|
|
CHEMBL3145
|
P42338
|
PI3-kinase p110-beta subunit |
83.57%
|
98.75%
|
|
CHEMBL2664
|
P23526
|
Adenosylhomocysteinase |
83.53%
|
86.67%
|
|
CHEMBL283
|
P08254
|
Matrix metalloproteinase 3 |
83.08%
|
97.29%
|
|
CHEMBL2534
|
O15530
|
3-phosphoinositide dependent protein kinase-1 |
82.46%
|
95.36%
|
|
CHEMBL4015
|
P41597
|
C-C chemokine receptor type 2 |
82.28%
|
98.57%
|
|
CHEMBL1075094
|
Q16236
|
Nuclear factor erythroid 2-related factor 2 |
82.02%
|
96.00%
|
|
CHEMBL1907603
|
Q05586
|
Glutamate NMDA receptor; GRIN1/GRIN2B |
81.78%
|
95.89%
|
|
CHEMBL3776
|
Q14790
|
Caspase-8 |
81.64%
|
97.06%
|
|
CHEMBL4203
|
Q9HAZ1
|
Dual specificity protein kinase CLK4 |
81.40%
|
94.45%
|
|
CHEMBL5028
|
O14672
|
ADAM10 |
81.00%
|
97.50%
|
|
CHEMBL1873
|
P00750
|
Tissue-type plasminogen activator |
80.64%
|
93.33%
|
|
CHEMBL4660
|
P28907
|
Lymphocyte differentiation antigen CD38 |
80.29%
|
95.27%
|
|
CHEMBL3238
|
P23786
|
Carnitine palmitoyltransferase 2 |
80.08%
|
94.05%
|